全文获取类型
收费全文 | 11866篇 |
免费 | 1016篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 190篇 |
儿科学 | 270篇 |
妇产科学 | 188篇 |
基础医学 | 1644篇 |
口腔科学 | 169篇 |
临床医学 | 1297篇 |
内科学 | 2486篇 |
皮肤病学 | 167篇 |
神经病学 | 1120篇 |
特种医学 | 424篇 |
外科学 | 1850篇 |
综合类 | 167篇 |
一般理论 | 27篇 |
预防医学 | 1027篇 |
眼科学 | 180篇 |
药学 | 821篇 |
中国医学 | 7篇 |
肿瘤学 | 884篇 |
出版年
2024年 | 10篇 |
2023年 | 110篇 |
2022年 | 154篇 |
2021年 | 410篇 |
2020年 | 233篇 |
2019年 | 400篇 |
2018年 | 526篇 |
2017年 | 368篇 |
2016年 | 357篇 |
2015年 | 378篇 |
2014年 | 531篇 |
2013年 | 574篇 |
2012年 | 999篇 |
2011年 | 979篇 |
2010年 | 572篇 |
2009年 | 492篇 |
2008年 | 801篇 |
2007年 | 791篇 |
2006年 | 740篇 |
2005年 | 734篇 |
2004年 | 685篇 |
2003年 | 510篇 |
2002年 | 518篇 |
2001年 | 90篇 |
2000年 | 64篇 |
1999年 | 86篇 |
1998年 | 91篇 |
1997年 | 76篇 |
1996年 | 63篇 |
1995年 | 52篇 |
1994年 | 53篇 |
1993年 | 42篇 |
1992年 | 28篇 |
1991年 | 31篇 |
1990年 | 39篇 |
1989年 | 40篇 |
1988年 | 35篇 |
1987年 | 28篇 |
1986年 | 31篇 |
1985年 | 30篇 |
1984年 | 20篇 |
1983年 | 22篇 |
1982年 | 14篇 |
1981年 | 19篇 |
1980年 | 16篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1973年 | 6篇 |
1972年 | 8篇 |
1969年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Janitz Amanda E. Schraw Jeremy M. Xu Chao Lupo Philip J. 《Cancer causes & control : CCC》2022,33(3):483-488
Cancer Causes & Control - Congenital malformations are strong risk factors for childhood cancer. Our objective was to determine whether cancer survival differs by birth defect status among... 相似文献
2.
3.
Alan. B. Franklin Sarah N. Bevins Jeremy W. Ellis Ryan S. Miller Susan A. Shriner J. Jeffrey Root Daniel P. Walsh Thomas J. Deliberto 《Transboundary and Emerging Diseases》2019,66(2):705-714
Using data on waterfowl band recoveries, we identified spatially explicit hotspots of concentrated waterfowl movement to predict occurrence and spatial spread of a novel influenza A virus (clade 2.3.4.4) introduced from Asia by waterfowl from an initial outbreak in North America in November 2014. In response to the outbreak, the hotspots of waterfowl movement were used to help guide sampling for clade 2.3.4.4 viruses in waterfowl as an early warning for the US poultry industry during the outbreak . After surveillance sampling of waterfowl, we tested whether there was greater detection of clade 2.3.4.4 viruses inside hotspots. We found that hotspots defined using kernel density estimates of waterfowl band recoveries worked well in predicting areas with higher prevalence of the viruses in waterfowl. This approach exemplifies the value of ecological knowledge in predicting risk to agricultural security. 相似文献
4.
5.
6.
7.
8.
Approximately 36 400 cardiac and 23 100 thoracic operations are carried out in the United Kingdom between 2006 and 2015. National Health Service (NHS) resolution, as known as the NHS litigation authority, is one of the essential bodies of the Department of Health. Its purpose is to provide NHS expertise to resolve concerns fair and square share learning for improvement. We aim to evaluate and increase awareness of medicolegal cases in cardiothoracic surgery. Total numbers and details of claims coded by NHS resolution in cardiothoracic surgery from 2004 to 2017 were requested under the Freedom of Information Act 2000. The data provided in successful claims is further breakdown into damages paid to the claimant, defence cost, claimant cost paid and the sum of the three. In contrast, unsuccessful claims only include the defence cost. Moreover, data provided also includes further analysis of primary causes and primary injuries for Claims Closed/Settled with damages paid. There were 753 claims recorded from 2004 to 2017, of which 415 (55.11%) were successful. The number of claims has been steadily increasing since 2004, with two significant raises from 2009/10 to 2010/11 (37‐55, 48.64% raise) and 2012/13 to 2013/14 (49‐69, 40.82% raise). The mean successful claim ratio was 69.58% (range, 47.56%‐ 83.33%) There is also a steady increase in the successful ratio from 2004 to 2017. In summary, this is the first study published in relation to litigation claims on cardiothoracic surgery in the United Kingdom. The results have provided insight on claims made against cardiothoracic surgery. 相似文献
9.
Hazel B Breitz Richard E Wendt Michael S Stabin Sui Shen William D Erwin Joseph G Rajendran Janet F Eary Lawrence Durack Ebrahim Delpassand William Martin Ruby F Meredith 《Journal of nuclear medicine》2006,47(3):534-542
166Ho-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene-phosphonate (DOTMP) is a tetraphosphonate molecule radiolabeled with 166Ho that localizes to bone surfaces. This study evaluated pharmacokinetics and radiation-absorbed dose to all organs from this beta-emitting radiopharmaceutical. METHODS: After two 1.1-GBq administrations of 166Ho-DOTMP, data from whole-body counting using a gamma-camera or uptake probe were assessed for reproducibility of whole-body retention in 12 patients with multiple myeloma. The radiation-absorbed dose to normal organs was estimated using MIRD methodology, applying residence times and S values for 166Ho. Marrow dose was estimated from measured activity retained after 18 h. The activity to deliver a therapeutic dose of 25 Gy to the marrow was determined. Methods based on region-of-interest (ROI) and whole-body clearance were evaluated to estimate kidney activity, because the radiotracer is rapidly excreted in the urine. The dose to the surface of the bladder wall was estimated using a dynamic bladder model. RESULTS: In clinical practice, gamma-camera methods were more reliable than uptake probe-based methods for whole-body counting. The intrapatient variability of dose calculations was less than 10% between the 2 tracer studies. Skeletal uptake of 166Ho-DOTMP varied from 19% to 39% (mean, 28%). The activity of 166Ho prescribed for therapy ranged from 38 to 67 GBq (1,030-1,810 mCi). After high-dose therapy, the estimates of absorbed dose to the kidney varied from 1.6 to 4 Gy using the whole-body clearance-based method and from 8.3 to 17.3 Gy using the ROI-based method. Bladder dose ranged from 10 to 20 Gy, bone surface dose ranged from 39 to 57 Gy, and doses to other organs were less than 2 Gy for all patients. Repetitive administration had no impact on tracer biodistribution, pharmacokinetics, or organ dose. CONCLUSION: Pharmacokinetics analysis validated gamma-camera whole-body counting of 166Ho as an appropriate approach to assess clearance and to estimate radiation-absorbed dose to normal organs except the kidneys. Quantitative gamma-camera imaging is difficult and requires scatter subtraction because of the multiple energy emissions of 166Ho. Kidney dose estimates were approximately 5-fold higher when the ROI-based method was used rather than the clearance-based model, and neither appeared reliable. In future clinical trials with 166Ho-DOTMP, we recommend that dose estimation based on the methods described here be used for all organs except the kidneys. Assumptions for the kidney dose require further evaluation. 相似文献
10.